We are monitoring the impact of COVID-19 on Latin America Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2723
Share on
Share on

Latin America Plasma Fractionation Market Research Report – Segmented By Product, Application, End User & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVId-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2723
Pages: 145

Latin America Plasma Fractionation Market Size (2021 to 2026)

The size of the Latin American Plasma Fractionation Market size was worth USD 3.51 billion in 2021. This value is projected to be growing at a CAGR of 5.2% to touch USD 4.53 billion by 2026.

Plasma is the liquid portion of blood. It consists of red cells, white cells, and platelets suspended in it and also contains thousands of distinct proteins and other materials like electrolytes, minerals, hormones, etc., which are essential for the regular function of the human body. Plasma supports in maintaining blood pressure and body temperature management.

There are many therapeutic uses for the proteins present in plasma. For example, Albumin is commonly used to rejuvenate and maintain blood volume after traumatic injury, surgery, and plasma interchange.

The increasing demand for plasma proteins and the increasing prevalence of rare diseases across Latin America is expected to propel the Latin America plasma fractionation market. In addition, the growth of the Latin America Plasma Fractionation Market is further driven by factors such as the high prevalence of blood disorders spread among a vast population base, growing awareness about blood abnormalities, and the leaps in technological, clinical advancements.

Adversarial reactions associated with the procedure of plasma fractionation and transfer, high costs of plasma products, and unfavorable reimbursement policies are the main constraints of market growth. In addition, high prices of plasma derivatives and the risk factors, coupled with the rising utilization of recombinant proteins and products that behave as a substitute for the plasma products, are expected to hamper the growth of the Latin American plasma fractionation market.

This research report on the Latin America plasma fractionation market has been segmented and sub-segmented into the following categories:

By Product: 

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Protease Inhibitors

By Application: 

  • Neurology
  • Hematology
  • Rheumatology
  • Pulmonology
  • Immunology

By End User: 

  • Hospitals
  • Clinical Laboratories

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

In Latin America, the Brazilian plasma fractionation market dominated Latin American in 2020 due to the rise in plasma collection and the number of plasma collection centers. Besides, the increasing incidences of blood and immune disorders are owing to the rising geriatric population.

The Mexican plasma fractionation market is projected to showcase a significant growth rate during the forecast period. Increasing demand from patients for excellent and technically advanced healthcare facilities and increased acquisition of innovative and advanced technologies boost Mexico's market. Rising off-label utilization of critical plasma products such as albumins is expected to drive the Mexico plasma fractionation market.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the Latin American plasma fractionation market profiled in the report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  2. Latin America Immunoglobulin Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Coagulation Factor Concentrates Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Albumin Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Protease Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Other Plasma Products Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  8. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Immunology Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Hematology Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Critical Care Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Pulmonology Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Hemato-oncology Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Rheumatology Market, By Region, From 2021 to 2026 (USD Million)
  15. Latin America Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Plasma Fractionation Market, By End User, From 2021 to 2026 (USD Million)
  17. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  18. Latin America Clinical Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  19. Latin America Academic Institutes Market, By Region, From 2021 to 2026 (USD Million)
  20. Brazil Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  21. Brazil Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  22. Brazil Plasma Fractionation Market, By End User, From 2021 to 2026 (USD Million)
  23. Argentina Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  24. Argentina Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  25. Argentina Plasma Fractionation Market, By End User, From 2021 to 2026 (USD Million)
  26. Mexico Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  27. Mexico Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  28. Mexico Plasma Fractionation Market, By End User, From 2021 to 2026 (USD Million)
  29. Rest of Latin America Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  30. Rest of Latin America Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  31. Rest of Latin America Plasma Fractionation Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample